Annals of the Rheumatic Diseases · 2022 · 30 citations · 42 references
Life SciencesImmunologyPathologyAutoimmunityImmunopathologyInflammationAutoantibodiesAutoimmune Disease PathologyAutoimmune DiseasesComplement SystemComplement-mediated InjuryIdiopathic Inflammatory MyopathiesAutoimmune MyositisComplement In Autoimmune DiseaseComplement-mediated AutoimmunityComplement-mediated DiseaseComplement-mediated Skin InjuryCutaneous Blood VesselsMyositis-associated AutoantibodiesMyositis-specific Autoantibodies
Background Idiopathic inflammatory myopathies (IIM) are a group of autoimmune diseases characterised by myositis-related autoantibodies plus infiltration of leucocytes into muscles and/or the skin, leading to the destruction of blood vessels and muscle fibres, chronic weakness and fatigue. While complement-mediated destruction of capillary endothelia is implicated in paediatric and adult dermatomyositis, the complex diversity of complement C4 in IIM pathology was unknown. Methods We elucidated the gene copy number (GCN) variations of total C4 , C4A and C4B, long and short genes in 1644 Caucasian patients with IIM, plus 3526 matched healthy controls using real-time PCR or Southern blot analyses. Plasma complement levels were determined by single radial immunodiffusion. Results The large study populations helped establish the distribution patterns of various C4 GCN groups. Low GCNs of C4T ( C4T =2+3) and C4A deficiency ( C4A =0+1) were strongly correlated with increased risk of IIM with OR equalled to 2.58 (2.28–2.91), p=5.0×10 −53 for C4T , and 2.82 (2.48–3.21), p=7.0×10 −57 for C4A deficiency. Contingency and regression analyses showed that among patients with C4A deficiency, the presence of HLA-DR3 became insignificant as a risk factor in IIM except for inclusion body myositis (IBM), by which 98.2% had HLA-DR3 with an OR of 11.02 (1.44–84.4). Intragroup analyses of patients with IIM for C4 protein levels and IIM-related autoantibodies showed that those with anti-Jo-1 or with anti-PM/Scl had significantly lower C4 plasma concentrations than those without these autoantibodies. Conclusions C4A deficiency is relevant in dermatomyositis, HLA-DRB1*03 is important in IBM and both C4A deficiency and HLA-DRB1*03 contribute interactively to risk of polymyositis.
42
Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens
Xiaoming Jia, Buhm Han, Suna Önengüt-Gümüşcü et al. · PLoS ONE · 2013 · 715 citations · Full text
Life Sciences, Genetics, Immunology +17
Yan Yang, Erwin K. Chung, Yee Ling Wu et al. · The American Journal of Human Genetics · 2007 · 468 citations · Full text
Neil McHugh, Sarah Tansley · Nature Reviews Rheumatology · 2018 · 385 citations